luminespib (Compound)
Synonyms:Luminespib, 747412-49-3, NVP-AUY922, AUY922, VER-52296, AUY-922, 5-(2,4-dihydroxy-5-isopropylphenyl)-N-ethyl-4-(4-(morpholinomethyl)phenyl)isoxazole-3-carboxamide, Luminespib (NVP-AUY922), AUY922 (NVP-AUY922), Luminespib (AUY-922 ), VER 52296, NVP-AUY 922, C6V1DAR5EB, NVP-AUY922-NX, Luminespib (AUY-922, NVP-AUY922), NVP-AUY-922, 5-[2,4-DIHYDROXY-5-ISOPROPYLPHENYL]-N-ETHYL-4-[4-(4-MORPHOLINYLMETHYL)PHENYL]-3-ISOXAZOLECARBOXAMIDE, CHEMBL3900791, CHEBI:83656, 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide, 5-[2,4-Dihydroxy-5-(1-Methylethyl)phenyl]-N-Ethyl-4-[4-(Morpholin-4-Ylmethyl)phenyl]isoxazole-3-Carboxamide, Luminespib [USAN:INN], UNII-C6V1DAR5EB, NVR-AUY 922, Isoxazole, 40f, 2GJ, VER-52296/NVP-AUY922, LUMINESPIB [INN], Luminespib (USAN/INN), LUMINESPIB [USAN], Luminespib; NVP-AUY922, LUMINESPIB [WHO-DD], MLS006011081, SCHEMBL892205, CHEMBL252164, GTPL9261, SCHEMBL2682235, AUY922,NVP-AUY922, LUMINESPIB(NVP-AUY922), BDBM20926, CHEBI:91422, EX-A611, BCPP000145, DTXSID001336117, HMS3295K23, HMS3654C15, AUY922 - NVP-AUY922, BCP01827, BDBM50274536, MFCD14635361, NSC755762, s1069, AKOS015966502, AKOS026750297, BCP9001007, CCG-264804, CS-0136, NSC-755762, SB16640, NCGC00247878-01, NCGC00387853-03, 5-(2,4-dihydroxy-5-propan-2-ylphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxamide, 5-[2,4-Dihydroxy-5-(1-methylethyl)phenyl]-N-ethyl-4-[4-(4-morpholinylmethyl)phenyl]-3-isoxazolecarboxamide, AC-33144, AS-17014, HY-10215, SMR004702869, A9562, FT-0700359, SW219319-1, CAS:747412-49-3;NVP-AUY922, D10646, J-516600, BRD-K41859756-001-01-9, Q10859697, Q27082304, Q27163272, AUY922; VER-52296; AUY 922; VER 52296; AUY-922; VER-52296, 5-(2,4-DIHYDROXY-5-(PROPAN-2-YL)PHENYL)-N-ETHYL-4-(4-((MORPHOLIN-4-YL)METHYL)PHENYL(-1,2-OXAZOLE-3-CARBOXAMIDE, 5-(2,4-dihydroxy-5-isopropylphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxamide, 5-[2,4-dihydroxy-5-(propan-2-yl)phenyl]-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxamide, N-ethyl-5-(4-hydroxy-6-oxo-3-propan-2-yl-1-cyclohexa-2,4-dienylidene)-4-[4-(4-morpholinylmethyl)phenyl]-2H-isoxazole-3-carboxamide
Pubchem:PUBCHEM:53401173
Id:4725cdbd-1334-52b6-aea6-8e5b72c9fc03
Description:nan
Analyze
CFDE DD-Knowledge Graph
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View luminespib's neighborhood in the knowledge graph.
GDLPA Landing Pages Links
The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for luminespib.
Playbook Workflow Builder
The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with luminespib.
Results found
Linked to
| Label | Description |
|
|---|---|---|---|
 | A Substance | ||
 | Metadatata for nvp-auy922 | ||
| A Knowledge Graph Assertion from IDG | ||
| A Knowledge Graph Assertion from IDG |
Metadatata for nvp-auy922
A Knowledge Graph Assertion from IDG
A Knowledge Graph Assertion from IDG
DISPLAY PER PAGE
10
@CFDE Workbench 2025
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
@CFDE Workbench 2025